Skip to main content
Benaroya Research Institute

Main navigation

  • About BRI
    • Leadership
    • Faculty
    • Administrative Leaders
    • Together We Discover
    • Contact Us
  • Our Research
    • Centers of Discovery
      • Fundamental Immunology
      • Translational Immunology
      • Interventional Immunology
      • Systems Immunology
        • Bioinformatics at BRI
    • Labs
    • Biorepositories
      • Be a Part of BRI Research
    • Clinical Research
      • Allergies & Asthma Clinical Research
    • Core Labs
      • Cell And Tissue Analysis Group
      • Genomics Core
      • Human Immunophenotyping Core
      • Protein and Tetramer Core
        • Protein & Tetramer Core Ordering
    • Immune Tolerance Network
    • Scientific Publications
    • Scientific Meetings at BRI
      • Asthma Research Symposium
      • BRI Immunology Symposium: New Horizons in Immunity and Disease
      • Cross Autoimmunity Prevention Symposium
  • Collaborations with BRI
    • Opportunities for Collaboration
    • Technology Available for Licensing
  • News
    • Press Releases
  • Support our Research
    • Donate Now
    • BRI Events
      • BRI Open House
      • Immunology to Change Lives

Utility Menu

  • Immunology Learning Center
  • Autoimmune Life Blog
  • Careers
  • Clinical Research at VMMC
  • Donate
  • Search
    • Jul 2014

      Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy.

      Arthritis Rheumatol
      James EA, Rieck M, Pieper J, Gebe JA, Yue BB, Tatum M, Peda M, Sandin C, Klareskog L, Malmström V, Buckner JH
    • Mar 2014

      Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner.

      J Allergy Clin Immunol
      Wambre E, DeLong JH, James EA, Torres-Chinn N, Pfützner W, Möbs C, Durham SR, Till SJ, Robinson D, Kwok WW
    • Dec 2013

      Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.

      J Autoimmun
      Dahan R, Gebe JA, Preisinger A, James EA, Tendler M, Nepom GT, Reiter Y
    • Dec 2013

      Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.

      J Virol
      James EA, LaFond RE, Gates TJ, Mai DT, Malhotra U, Kwok WW
    • Aug 2013

      CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination.

      Int Immunol
      Yang J, James EA, Gates TJ , DeLong JH , LaFond RE , Malhotra U , Kwok WW
    • May 2013

      Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.

      J Immunol
      Chow IT, James EA, Gates TJ, Tan V, Moustakas AK, Papadopoulos GK, Kwok WW
    • Mar 2013

      CD4+ T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring.

      Immunology
      Yang J, James EA, Sanda S, Greenbaum CJ, Kwok WW
    • Jan 2013

      Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset.

      PLoS Pathog
      Lindestam Arlehamn CS, Gerasimova A, Mele F, Henderson R, Swann J, Greenbaum JA, Kim Y, Sidney J, James EA, Taplitz R, McKinney DM, Kwok WW, Grey H, Sallusto F, Peters B, Sette A
    • Dec 2012

      Characterization of CD4+ T cell subsets in allergy.

      Curr Opin Immunol
      Wambre E, James EA, Kwok WW
    • May 2012

      Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ).

      J Immunol
      Arlehamn CS, Sidney J, Henderson R, Greenbaum JA, James EA, Moutaftsi M, Coler R, McKinney DM, Park D, Taplitz R, Kwok WW, Grey H, Peters B, Sette A
    • Mar 2012

      Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire.

      J Immunol
      Kwok WW, Tan V, Gillette L, Littell CT, Soltis MA, LaFond RB, Yang J, James EA, DeLong JH
    • Feb 2012

      DRB1*12:01 presents a unique subset of epitopes by preferring aromatics in pocket 9.

      Mol Immunol
      Chow IT, James EA, Tan V, Moustakas AK, Papadopoulos GK, Kwok WW
    • Feb 2012

      Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy.

      J Allergy Clin Immunol
      Wambre E, DeLong JH, James EA, LaFond RE, Robinson D, Kwok WW
    • Nov 2011

      Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative.

      Diabetes Metab Res Rev
      James EA, Mallone R, Schloot NC, Gagnerault MC, Thorpe J, Fitzgerald-Miller L, Reichow J, Wagner R, Pham MN, Jospe N, Lou O, Gottlieb PA, Brooks-Worrell BM, Durinovic-Belló I, T-Cell Workshop Committee, Immunology of Diabetes Society.
    • Nov 2011

      Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.

      Diabetes Metab Res Rev
      Mallone R, Scotto M, Janicki CN, James EA, Fitzgerald-Miller L, Wagner R, Gottlieb P, Thorpe J, Jospe N, Durinovic-Belló I, Boitard C, Lou O, Dayan CM, Wong FS, T-Cell Workshop Committee, Immunology of Diabetes Society

Pagination

First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Next page Next › Last page Last »
Benaroya Research Institute

1201 Ninth Avenue
Seattle, WA 98101-2795
(206) 342-6500

facebook Bluesky instagram linkedin youtube threads
Resources
  • Support our Research
  • Subscribe to News
  • Careers
  • Contact Us
  • Research Conflicts of Interest
  • Research Security Program
  • Terms of Use
  • Research Requirements
If you would like to contact us regarding the accessibility of our website, please contact us at 206-342-6500 or email communications@benaroyaresearch.org.
© 2025 Benaroya Research Institute, a 501(c)(3) nonprofit organization
Close Close